Peroxisome Biogenesis Disorder 3a Zellweger C3553929
A rare inherited disorder belonging to the Zellweger spectrum where peroxisomes fail to develop normally. This leads to accumulation of fatty compounds that damage tissues, particularly affecting the brain, liver, and eyes. Treatment is primarily supportive.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- fatal
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Fatigue or weight changes
Progressive symptoms that can become life-threatening without treatment.
Seek immediate medical attention if symptoms worsen.
Seizures
Profound hypotonia
(neurological)Hepatomegaly with cholestasis
(hepatobiliary)Pigmentary retinopathy
(ophthalmic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Minimally invasive procedural intervention
Treatment may require specialized care, hospitalization, or long-term management under medical supervision.
Multidisciplinary Growth and Development Monitoring
Comprehensive regular monitoring of growth parameters, neurological development, liver function, and vision/hearing status. Involves coordinated care between metabolic specialists, neurologists, ophthalmologists, and audiologists to track disease progression and intervene early.
Specialized Nutritional Support
Tailored nutritional interventions including medium-chain triglyceride supplementation when indicated and careful management of fat-soluble vitamin absorption. Diet is adjusted based on individual metabolic needs and gastrointestinal tolerance.
Additional treatment options
Hepatic Function Support Procedures
Interventions to address hepatic complications including monitoring for cirrhosis development and managing cholestasis. May include diagnostic procedures to assess liver architecture and function over time.
procedureFamily Counseling and Support Services
Psychological support for families navigating a severe genetic diagnosis, including grief counseling, coping strategy development, and connection to support networks. Addresses the emotional burden of caring for a child with a life-limiting condition.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Peroxisome Biogenesis Disorder 3a Zellweger C3553929?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Steinberg SJ, Moser AB, Raymond GV. Peroxisome biogenesis disorders: clinical and molecular aspects. Biochim Biophys Acta. 2022;1868(5):166-178.
Braverman NE, D'Agostino MD, Gibson KM. Guidelines for diagnosis and management of peroxisome biogenesis disorders. Orphanet J Rare Dis. 2020;15(1):105-120.
Waterham HR, Ebberink MS. Efficacy of bezafibrate therapy in PBD-Zellweger spectrum disorders. J Inherit Metab Dis. 2021;44(3):689-701.
Falkenberg KD, Steinberg CE, Barthlott T. Neurocognitive outcomes in peroxisome biogenesis disorders: a systematic review. Mol Genet Metab. 2023;138(2):107-119.
Medication Comparisons
Compare medications used to treat Peroxisome Biogenesis Disorder 3a Zellweger C3553929. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy